Low-Density Lipoprotein Cholesterol and Drug Treatment to Lower Atherosclerotic Cardiovascular Disease Risk: Where Do We Stand? [electronic resource]
Producer: 20190603Description: 937-938 p. digitalISSN:- 2380-6591
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Anticholesteremic Agents -- therapeutic use
- Atherosclerosis -- blood
- Cholesterol, LDL -- blood
- Drug Therapy, Combination
- Ezetimibe -- therapeutic use
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypercholesterolemia -- blood
- PCSK9 Inhibitors
- Patient Selection
- RNA, Small Interfering -- therapeutic use
- Risk Reduction Behavior
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.